These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23581611)

  • 1. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
    Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
    Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.
    Walters S; Maringe C; Coleman MP; Peake MD; Butler J; Young N; Bergström S; Hanna L; Jakobsen E; Kölbeck K; Sundstrøm S; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Linklater KM; McGahan CE; Steward J; Tracey E; Turner D; Richards MA; Rachet B;
    Thorax; 2013 Jun; 68(6):551-64. PubMed ID: 23399908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
    Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
    Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.
    Maringe C; Walters S; Butler J; Coleman MP; Hacker N; Hanna L; Mosgaard BJ; Nordin A; Rosen B; Engholm G; Gjerstorff ML; Hatcher J; Johannesen TB; McGahan CE; Meechan D; Middleton R; Tracey E; Turner D; Richards MA; Rachet B;
    Gynecol Oncol; 2012 Oct; 127(1):75-82. PubMed ID: 22750127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
    Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
    Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Wärnberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP;
    Br J Cancer; 2013 Mar; 108(5):1195-208. PubMed ID: 23449362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
    Pilleron S; Charvat H; Araghi M; Arnold M; Fidler-Benaoudia MM; Bardot A; Grønlie Guren M; Tervonen H; Little A; O'Connell DL; Gavin A; De P; Aagard Thomsen L; Møller B; Jackson C; Bucher O; Walsh PM; Vernon S; Bray F; Soerjomataram I
    Int J Cancer; 2021 Apr; 148(7):1575-1585. PubMed ID: 33006395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
    Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
    Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
    Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
    Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?
    Forbes LJ; Simon AE; Warburton F; Boniface D; Brain KE; Dessaix A; Donnelly C; Haynes K; Hvidberg L; Lagerlund M; Lockwood G; Tishelman C; Vedsted P; Vigmostad MN; Ramirez AJ; Wardle J;
    Br J Cancer; 2013 Feb; 108(2):292-300. PubMed ID: 23370208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.
    Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP
    Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
    Araghi M; Soerjomataram I; Bardot A; Ferlay J; Cabasag CJ; Morrison DS; De P; Tervonen H; Walsh PM; Bucher O; Engholm G; Jackson C; McClure C; Woods RR; Saint-Jacques N; Morgan E; Ransom D; Thursfield V; Møller B; Leonfellner S; Guren MG; Bray F; Arnold M
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):511-518. PubMed ID: 31105047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
    Arnold M; Morgan E; Bardot A; Rutherford MJ; Ferlay J; Little A; Møller B; Bucher O; De P; Woods RR; Saint-Jacques N; Gavin AT; Engholm G; Achiam MP; Porter G; Walsh PM; Vernon S; Kozie S; Ramanakumar AV; Lynch C; Harrison S; Merrett N; O'Connell DL; Mala T; Elwood M; Zalcberg J; Huws DW; Ransom D; Bray F; Soerjomataram I
    Gut; 2022 Aug; 71(8):1532-1543. PubMed ID: 34824149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004.
    Morris EJ; Sandin F; Lambert PC; Bray F; Klint A; Linklater K; Robinson D; Påhlman L; Holmberg L; Møller H
    Gut; 2011 Aug; 60(8):1087-93. PubMed ID: 21303917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000.
    Engholm G; Kejs AM; Brewster DH; Gaard M; Holmberg L; Hartley R; Iddenden R; Møller H; Sankila R; Thomson CS; Storm HH
    Int J Cancer; 2007 Sep; 121(5):1115-22. PubMed ID: 17455250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK.
    Lachmann P
    Lancet; 2011 Apr; 377(9772):1149; author reply 1149-50. PubMed ID: 21459202
    [No Abstract]   [Full Text] [Related]  

  • 20. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.